BR0013958A - Dieta de elevado teor de lipìdios - Google Patents

Dieta de elevado teor de lipìdios

Info

Publication number
BR0013958A
BR0013958A BR0013958-0A BR0013958A BR0013958A BR 0013958 A BR0013958 A BR 0013958A BR 0013958 A BR0013958 A BR 0013958A BR 0013958 A BR0013958 A BR 0013958A
Authority
BR
Brazil
Prior art keywords
composition
high lipid
medicament
lipid diet
nutritional product
Prior art date
Application number
BR0013958-0A
Other languages
English (en)
Inventor
Marco Turini
Claudia Roessle
Denis Breuille
Gayle Crozier-Willi
Paul-Andre Finot
Myriam Richelle
Guy Dutot
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238988&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0013958(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0013958A publication Critical patent/BR0013958A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Patente de Invenção: "DIETA DE ELEVADO TEOR DE LIPìDIOS". é descrita uma composição para utilização como um medicamento ou produto nutricional que compreende pelo menos um lipídio em que o lipídio proporciona mais de 35% da energia total da composição. Uma concretização preferida compreende uma relação de ácidos graxos n-6/n-3 de cerca de 2/1 a 7/1. Adicionalmente, são descritos um processo de preparação da composição; utilização da composição na fabricação de um medicamento ou produto nutricional; e a um processo de tratamento ou prevenção de sepse ou choque inflamatório que compreende a administração de uma quantidade efetiva da composição.
BR0013958-0A 1999-09-13 2000-09-07 Dieta de elevado teor de lipìdios BR0013958A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99118173A EP1090636A1 (en) 1999-09-13 1999-09-13 High lipid diet
PCT/EP2000/008731 WO2001019356A2 (en) 1999-09-13 2000-09-07 High lipid diet

Publications (1)

Publication Number Publication Date
BR0013958A true BR0013958A (pt) 2002-05-14

Family

ID=8238988

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013958-0A BR0013958A (pt) 1999-09-13 2000-09-07 Dieta de elevado teor de lipìdios

Country Status (13)

Country Link
US (2) US6995189B1 (pt)
EP (2) EP1090636A1 (pt)
CN (1) CN1222284C (pt)
AT (1) ATE258792T1 (pt)
AU (1) AU6843000A (pt)
BR (1) BR0013958A (pt)
CA (1) CA2384859C (pt)
DE (1) DE60008127T2 (pt)
ES (1) ES2213036T3 (pt)
HK (1) HK1052298B (pt)
MX (1) MXPA02002728A (pt)
PT (1) PT1216041E (pt)
WO (1) WO2001019356A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1561218A (zh) * 2001-07-27 2005-01-05 努特里奇亚有限公司 用于预防和/或治疗败血症的肠道组合物
JP2006516614A (ja) * 2003-02-05 2006-07-06 エヌ．ブイ．・ヌートリシア 敗血症の予防および／または治療のための経腸組成物
BRPI0517336A (pt) * 2004-11-12 2008-10-07 Nutricia Nv usos de uma fração de proteìna e uma fração de lipìdeo e de uma composição nutricional, composição nutricional, e, método de rapidamente atenuar resposta inflamatória aguda
US8821947B2 (en) * 2006-06-01 2014-09-02 Howard W. Selby, III Cholesterol-reducing diet
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
CA2664139C (en) * 2006-10-19 2013-08-13 Nestec S.A. Nutritional product for long-term feeding of elderly
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
MX2010000224A (es) 2007-06-26 2010-05-03 Nutricia Nv Mejoramiento de la memoria en individuos con mini-examen de estado mental de 24-26.
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
CN101951923B (zh) 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品
EP2311486A1 (en) * 2009-10-07 2011-04-20 Nestec S.A. GLP-2 for use in intestine and muscle recovery
DK2409695T3 (en) 2010-07-05 2018-05-28 Beth Israel Deaconess Medical Ct Inc SN-2-MONOACYLGYLYCEROLS AND LIPID MALABSORPTION
WO2012138212A1 (en) 2011-04-06 2012-10-11 N.V. Nutricia Food composition for intra-operative tube feeding
CN104026591A (zh) * 2014-04-04 2014-09-10 上海英莱腾医药研究有限公司 一种含中链甘油三酯的多功能蛋白食品组合物
TWI722992B (zh) * 2014-07-23 2021-04-01 一般財團法人糧食研究會 腦功能改善劑、及認知功能障礙的預防或治療劑
US11162708B2 (en) * 2015-11-16 2021-11-02 Genie Enterprise Ltd. Apparatus for rapid heating of liquids
US20180185317A1 (en) * 2016-12-29 2018-07-05 Immodulon Therapeutics Limited Immunotherapeutic agent
CN108402467A (zh) * 2018-03-01 2018-08-17 苏州恒瑞健康科技有限公司 一种提高肿瘤患者营养需求的组合物及其应用、用于提高外源性脂肪利用率的食品及药品
BR112020024310A2 (pt) * 2018-07-10 2021-02-23 Société des Produits Nestlé S.A. formulações de tcm para aumentar a exposição à cetona e métodos para produzir e usar tais formulações
CN108703180A (zh) * 2018-08-29 2018-10-26 西安瑞仁生物技术有限公司 一种高纤、低碳、高脂的生酮饼干及其制备方法
JP2022534471A (ja) * 2019-05-31 2022-08-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 動物における健康効果を提供するためのｍｃｔベースの栄養ブレンド

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055446A (en) 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
DE69420124T2 (de) * 1993-01-15 2000-03-02 Abbott Laboratories, Abbott Park Strukturierte lipide
DE4304394A1 (en) * 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
US5723446A (en) * 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
CN1259908C (zh) * 1995-11-28 2006-06-21 B·布朗·梅尔松根有限公司 最优化水解的脂质乳剂及其用途
EP0852913A1 (en) * 1997-01-14 1998-07-15 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis

Also Published As

Publication number Publication date
US20050281864A1 (en) 2005-12-22
MXPA02002728A (es) 2002-08-30
EP1090636A1 (en) 2001-04-11
AU6843000A (en) 2001-04-17
US7691906B2 (en) 2010-04-06
US6995189B1 (en) 2006-02-07
HK1052298A1 (en) 2003-09-11
CA2384859A1 (en) 2001-03-22
EP1216041B1 (en) 2004-02-04
WO2001019356A3 (en) 2001-05-17
WO2001019356A2 (en) 2001-03-22
EP1216041A2 (en) 2002-06-26
PT1216041E (pt) 2004-05-31
CN1222284C (zh) 2005-10-12
DE60008127T2 (de) 2004-09-09
CN1390125A (zh) 2003-01-08
ES2213036T3 (es) 2004-08-16
ATE258792T1 (de) 2004-02-15
HK1052298B (zh) 2006-07-07
CA2384859C (en) 2007-07-03
DE60008127D1 (de) 2004-03-11

Similar Documents

Publication Publication Date Title
BR0013958A (pt) Dieta de elevado teor de lipìdios
NZ516101A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
FR2635263B1 (pt)
EP1787532A3 (en) Microbial oil mixtures and uses thereof
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
MY109928A (en) Fatty acid treatment
DE69935995D1 (de) Polyungesättigen fettsäuren nährungsergänzung
ATE236627T1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
ATE45091T1 (de) Pharmazeutische zubereitung mit speziellen 1,2diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich.
ATE81453T1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
DK0631772T3 (da) Retinoidholdig sammensætning
EP1637137A3 (en) Method and composition for administering a cyclooxygenase-2 inhibitor to animals
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
ATE142491T1 (de) Mittel zur behandlung des atopischen ekzems und anderen entzündlichen hautkrankheiten
IT1251226B (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
TW325404B (en) Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
HU913009D0 (en) Method for producing inhibitors of calcium ingestion
ATE91079T1 (de) Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
ITMI930273A0 (it) Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.